Correlation Engine 2.0
Clear Search sequence regions

  • dogs (14)
  • heart (1)
  • metastasis (2)
  • patients (1)
  • pharynx (1)
  • thyroid (2)
  • thyroid dysgenesis (1)
  • thyroid tumour (7)
  • Sizes of these terms reflect their relevance to your search.

    This study aimed to describe the clinical and diagnostic characteristics, as well as outcomes of radioiodine treatment in dogs with hyperthyroidism caused by a non-resectable ectopic thyroid tumour. This retrospective study reviewed the medical records between 2008 and 2018 of dogs diagnosed with hyperthyroidism secondary to a non-resectable ectopic thyroid tumour and treated with radioiodine. Five dogs were included in the study. Three dogs had sublingual ectopic tumours, of which one also had a unilateral cervical thyroid tumour. The remaining two dogs were diagnosed with an ectopic thyroid tumour at the level of the caudal pharynx and the heart base, respectively. All cases were treated with radioiodine. The size of the ectopic masses decreased after radioiodine treatment. Total thyroxine concentrations returned to reference ranges in all dogs. Further, clinical signs of hyperthyroidism disappeared after treatment in all patients. One dog developed myelosuppression secondary to radioiodine treatment. The dog with metastasis had a very short survival compared to the four dogs without metastasis (3 months compared to 7, 36, 50 and 24 months, respectively) and succumbed most likely to thyroid-related problems. In the remaining four dogs, their quality of life improved. They died due to diseases unrelated to the ectopic thyroid tumour. Radioiodine therapy should be considered as a treatment option in dogs diagnosed with hyperthyroidism due to a non-resectable ectopic thyroid tumour. © 2020 British Small Animal Veterinary Association.


    A Lyssens, M F van den Berg, K Peremans, E Vandermeulen, S Daminet. 131 treatment in dogs with hyperthyroidism caused by a non-resectable ectopic thyroid tumour: 5 cases (2008-2019). The Journal of small animal practice. 2021 Feb;62(2):137-144

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33150621

    View Full Text